HSV-tk

herpes simplex virus thymidine kinase

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HSV-tk, covering 2026-03-30 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM [Phase 1, Phase 2]